BIOTECHNOLOGY EUROPE OUT LICENSING

Community

Advertising Opportunities

Biotechnology Europe Programs

Resources

Biotechnology Europe Community

Feedback

Contact

Biotechnology Europe Advantages

Advertising Opportunities on Biotechnology Europe

Sponsorship Opportunities on Biotechnology Europe

Post a Job on Biotechnology Europe

Post a Company Profile on Biotechnology Europe

Post a News on Biotechnology Europe

Post an Event on Biotechnology Europe

Post a Product on Biotechnology Europe

Post a Publication on Biotechnology Europe

Post a Technology on Biotechnology Europe

Post a Resume on Biotechnology Europe

OUT LICENSING

New compound offers attractive therapeutic candidate for autoimmune inflammatory diseases

Scientists from Leiden University Medical Center have found a DNA marker that is associated with early stage carcinogenesis of colorectal cancer. The invention concerns a DNA marker that is methylated in tumor cells. More

I back I top I

office@biotechnology-europe.com I website@biotechnology-europe.com I service@biotechnology-europe.com